Funding enablement SJA focuses on fundraising for life sciences, supporting early-stage biotech and medical device companies through private placements, alternative public offerings, non-dilutive capital, and M&A; potential sales opportunity lies in expanding investor outreach services and partnering with fund managers seeking diversified deal flow.

Strategic partnerships SJA Consulting specializes in business development and licensing negotiations with major biopharma partners; opportunity to cross-sell expanded BD services, licensing deal structuring, and partner matchmaking to larger biotech players seeking strategic collaborations.

Market access SJA leverages non-dilutive funding sources (NIH, SBIR, CPRIT, state programs) to finance programs; potential upsell to clients for grant strategy, grant writing support, and government funding navigation as part of a broader financing package.

Tech and credibility The firm’s use of established platforms (HubSpot, Squarespace, WordPress) and a disclosed broker-dealer relationship signals a professional sales process; opportunity to offer enhanced investor CRM, content marketing, and regulatory-compliant outreach services to attract more capital partners.

Financial profile Reported revenue range and a lean employee base imply a boutique advisory model with high-margin services; potential sales angle includes scalable advisory bundles, retainer-based strategy work, and bundled fundraising rounds for emerging growth companies seeking efficient, integrated financing and M&A support.